Tag: Johnson & Johnson
-

Our diversified investing style proves its worth as the AI trade stumbles again
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
-

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
-

We’re trimming a health-care stock into strength and raising our price target
It’s been a remarkable turnaround for a name we started to buy a little too high and a little too fast when the Iran war broke out.
-

Goldman says stocks like Nvidia have more room to run
Analysts at Goldman Sachs named several stocks that have defensive attributes that they say also offer plenty of upside.
-

Pharma stocks are showing strength. Charts predict this name could break out next
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within healthcare.
Latest News

Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news china cup Donald J. Trump Donald Trump economy European Union fast football France germany Heatwave Investment strategy iran Iran war markets news People per politics return russia said Singapore spain Sport Stock markets technology trump ukraine United Kingdom United States US-Israel attack on Iran 2026 video War in Ukraine World world cup World Cup 2026
About the Author

AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed












